These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15853083)

  • 1. [Ezetimibe].
    Taéron C
    Rev Infirm; 2005 Mar; (109):43-4. PubMed ID: 15853083
    [No Abstract]   [Full Text] [Related]  

  • 2. Is it over for ezetimibe?
    Robinson JG; Davidson M
    Expert Rev Cardiovasc Ther; 2008 Jul; 6(6):781-3. PubMed ID: 18570614
    [No Abstract]   [Full Text] [Related]  

  • 3. [The current debate on lowering LDL cholesterol with ezetimibe].
    Erdmann E
    Dtsch Med Wochenschr; 2010 Sep; 135(36):1742. PubMed ID: 20812160
    [No Abstract]   [Full Text] [Related]  

  • 4. Liptruzet: a combination of ezetimibe and atorvastatin.
    Med Lett Drugs Ther; 2013 Jun; 55(1419):49-50. PubMed ID: 23797796
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of ezetimibe during HIV infection.
    Stebbing J; Asghar AK; Holmes P; Bower M; Isenman HL; Nelson M
    J Antimicrob Chemother; 2009 Jan; 63(1):218-20. PubMed ID: 18948409
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ezetimibe--intestinal cholesterol absorbtion inhibitor].
    Pikto-Pietkiewicz W; Pasierski T
    Kardiol Pol; 2006 Dec; 64(12):1434-41. PubMed ID: 17206545
    [No Abstract]   [Full Text] [Related]  

  • 7. Ezetimibe: cholesterol lowering and beyond.
    Bays HE; Neff D; Tomassini JE; Tershakovec AM
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):447-70. PubMed ID: 18402536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Making sense of ENHANCE: ezetimibe (Zetia) lowers LDL cholesterol but doesn't decrease carotid intima-media thickness.
    Smith D
    Mt Sinai J Med; 2008; 75(2):143-7. PubMed ID: 18500716
    [No Abstract]   [Full Text] [Related]  

  • 9. Ezetimibe revisited.
    Med Lett Drugs Ther; 2008 Aug; 50(1293):67-8. PubMed ID: 18719525
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ezetimib].
    Meyer Zu Schwabedissen H; Kroemer HK
    Dtsch Med Wochenschr; 2004 Sep; 129(39):2038-40. PubMed ID: 15386207
    [No Abstract]   [Full Text] [Related]  

  • 11. Ezetimibe for the treatment of primary (heterozygous-familial and non-familial) hypercholesterolaemia: NICE technology appraisal guidance.
    Charles Z; Pugh E; Barnett D
    Heart; 2008 May; 94(5):642-3. PubMed ID: 18411354
    [No Abstract]   [Full Text] [Related]  

  • 12. Utility of ezetimibe.
    Ashikaga H; Blumenthal RS; Jones SR
    Am J Cardiol; 2009 May; 103(9):1321-2. PubMed ID: 19406279
    [No Abstract]   [Full Text] [Related]  

  • 13. Cholesterol absorption inhibitors: a closer look.
    Lehmann R; Ramsey LA
    Adv Nurse Pract; 2003 Nov; 11(11):28-31. PubMed ID: 14639879
    [No Abstract]   [Full Text] [Related]  

  • 14. Ezetimibe: a new addition to lipid-lowering therapy.
    Wierzbicki AS
    Int J Clin Pract; 2003 Oct; 57(8):653-5. PubMed ID: 14627172
    [No Abstract]   [Full Text] [Related]  

  • 15. New drugs for treating lipid abnormalities.
    Frishman WH
    Heart Dis; 2002; 4(6):343. PubMed ID: 12441009
    [No Abstract]   [Full Text] [Related]  

  • 16. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Davis HR; Murgolo NJ; Graziano MP
    N Engl J Med; 2008 Jul; 359(5):531; author reply 532-3. PubMed ID: 18677799
    [No Abstract]   [Full Text] [Related]  

  • 17. Ezetimibe. The French authorities gradually confirm the lack of benefit.
    Prescrire Int; 2010 Jun; 19(107):115. PubMed ID: 20738036
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of effects of ezetimibe/simvastatin versus simvastatin versus atorvastatin in reducing C-reactive protein and low-density lipoprotein cholesterol levels.
    Pearson T; Ballantyne C; Sisk C; Shah A; Veltri E; Maccubbin D
    Am J Cardiol; 2007 Jun; 99(12):1706-1713. PubMed ID: 17560879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug utilization of ezetimibe in rehabilitation centres: registry analysis of factors influencing prescription and effectiveness of treatment.
    Bestehorn K; Völler H; Benecke H; Renner H; Karmann B; Wegscheider K
    Curr Med Res Opin; 2006 Apr; 22(4):631-9. PubMed ID: 16684423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid altering-efficacy of ezetimibe co-administered with simvastatin compared with rosuvastatin: a meta-analysis of pooled data from 14 clinical trials.
    Catapano A; Brady WE; King TR; Palmisano J
    Curr Med Res Opin; 2005 Jul; 21(7):1123-30. PubMed ID: 16004682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.